Odyssey Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis (NCT06850727) | Odyssey Therapeutics | 2025-06-02 |
| Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants (NCT06206811) | Odyssey Therapeutics | 2024-02-12 |
Track Odyssey Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.